Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1953-02-2

Post Buying Request

1953-02-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1953-02-2 Usage

Description

Different sources of media describe the Description of 1953-02-2 differently. You can refer to the following data:
1. Tiopronin is a sulfiydryl derivative of N-propylglycine useful in the treatment of cystine urolithiasis in children. It is also reportedly effective in the management of rheumatoid polyarthritis, possibly due to its inhibitory effect on the free oxygen radicals produced by inflammatory macrophages and granulocytes.
2. Tiopronin is an antioxidant that has diverse biological activities. It reduces free radical production by murine macrophages and granulocytes in vitro in a dose-dependent manner. Tiopronin induces expression of hypoxia-inducible factor 1α (HIF-1α) and increases VEGF secretion in human colon carcinoma cells. Rectal administration (500 μL of a 10 mM solution) reduces myeloperoxidase activity and reduces pro-inflammatory cytokine production in the colon in a rat model of colitis. Tiopronin (80-320 mg/kg per day) reduces the incidence of cleft palate in fetuses born to female mice orally exposed to teratogenic methylmercury chloride. Tiopronin (100 mg/kg) reduces heme oxygenase 1 mRNA expression, lipid peroxidation, and transverse aortic constriction in a mouse model of cardiac hypertrophy. Tiopronin (20 mg/kg) is hepatoprotective, increasing activity of the antioxidant enzymes superoxide dismutase and glutathione peroxidase and reversing hepatocyte degeneration in a rat model of high-fat diet-induced non-alcoholic steatohepatitis.

Chemical Properties

White Solid

Originator

Roussel-Uclaf (Japan)

Uses

Different sources of media describe the Uses of 1953-02-2 differently. You can refer to the following data:
1. It is used as antidote against heavy metal poisoning; hepatoprotectant; mucolytic.
2. N-(2-Mercaptopropionyl)glycine or Tiopronin has been used:in the preparation of polyethylenimine (PEI)-coated gold microparticles (PEI-gold) for biolistic delivery of nucleic acidsto study the role of reactive oxygen species (ROS) at the reperfusion stage in in vivo isoflurane preconditioning-induced neuroprotectionas a ROS inhibitor to study its effect on lysophosphatidylcholine (LPC)-induced inflammasome activation

Manufacturing Process

α-Benzylmercaptopropionic acid (melting point 76°C to 78°C; 100 g) prepared by condensation of α-mercaptopropionic acid with benzyl chloride is allowed to stand overnight with 80 g of thionyl chloride. After removal of excess thionyl chloride distillation in vacuo gives 70 g of α-benzylmercaptopropionic acid chloride of boiling point 138°C to 139°C/7 to 8 mm Hg. Then, 25 g of glycine is dissolved in 165 ml of 2 N sodium hydroxide solution and 70 g of α-benzylmercaptopropionic acid chloride and 100 ml of 2 N sodium hydroxide solution are dropped thereinto simultaneously at 3°C to 5°C. The solution is then stirred at room temperature for 3 to 4 hours to complete the reaction, the reaction solution is washed with ether, the aqueous layer is acidified with hydrochloric acid, and the resulting crystals are collected by filtration. These are recrystallized from a mixture of methanol and ethyl acetate to give 60 g of α-benzylmercaptopropionylglycine of melting point 133°C to 134°C. This α-benzylmercaptopropionylglycine (60 g) is dissolved in 400 ml of liquid ammonia, kept at about -50°C, and 12 g of sodium metal is gradually added thereto. After the reaction, excess ammonia is removed therefrom, the residue is dissolved in water, washed with ether and the residual aqueous layer is adjusted to pH 1 with hydrochloric acid and concentrated in vacuo in a stream of hydrogen sulfide. The crystalline residue is dried and recrystallized from ethyl acetate to give 25 g of α-mercaptopropionylglycine of melting point 95°C to 97°C.

Brand name

Thiola

Therapeutic Function

Antidote (heavy metal)

Biochem/physiol Actions

N-(2-Mercaptopropionyl)glycine (NMPG) is a thiol compound associated with autoimmune hypoglycemia. It is a diffusible antioxidant and reduces the severity of colonic injury. NMPG also relieves myeloperoxidase activity and stimulates hypoxia-inducible factor-1 (HIF-1) - vascular endothelial growth factor (VEGF) pathway for ulcer healing.

Veterinary Drugs and Treatments

Tiopronin is indicated for the prevention of cystine urolithiasis in patients where dietary therapy combined with urinary alkalinization is not completely effective. It may also be useful in combination with urine alkalinization to dissolve stones.

Check Digit Verification of cas no

The CAS Registry Mumber 1953-02-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,9,5 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1953-02:
(6*1)+(5*9)+(4*5)+(3*3)+(2*0)+(1*2)=82
82 % 10 = 2
So 1953-02-2 is a valid CAS Registry Number.
InChI:InChI=1/C5H9NO3S/c1-3(10)5(9)6-2-4(7)8/h3,10H,2H2,1H3,(H,6,9)(H,7,8)

1953-02-2 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (T2614)  Tiopronin  >97.0%(GC)(T)

  • 1953-02-2

  • 5g

  • 710.00CNY

  • Detail
  • TCI America

  • (T2614)  Tiopronin  >97.0%(GC)(T)

  • 1953-02-2

  • 25g

  • 1,790.00CNY

  • Detail
  • Sigma

  • (M6635)  N-(2-Mercaptopropionyl)glycine  

  • 1953-02-2

  • M6635-5G

  • 773.37CNY

  • Detail
  • Sigma

  • (M6635)  N-(2-Mercaptopropionyl)glycine  

  • 1953-02-2

  • M6635-10G

  • 1,429.74CNY

  • Detail
  • Sigma

  • (M6635)  N-(2-Mercaptopropionyl)glycine  

  • 1953-02-2

  • M6635-100G

  • 8,073.00CNY

  • Detail
  • Sigma-Aldrich

  • (33986)  Tiopronin  VETRANAL, analytical standard

  • 1953-02-2

  • 33986-100MG-R

  • 870.48CNY

  • Detail

1953-02-2Synthetic route

2-chloropropionylglycine
85038-45-5

2-chloropropionylglycine

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

Conditions
ConditionsYield
Stage #1: 2-chloropropionylglycine With sodium disulfide; sulfuric acid; sodium carbonate In water at 45℃; for 0.05h; Large scale;
Stage #2: With sulfuric acid; zinc at 5 - 20℃; for 1.05h; Temperature; Large scale;
76.5%
N-(2-bromo-propionyl)-glycine
25413-03-0

N-(2-bromo-propionyl)-glycine

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

Conditions
ConditionsYield
With hydrogen sulfide; sodium methylate In methanol
α-Ethylxanthogenpropionylglycin
6182-95-2

α-Ethylxanthogenpropionylglycin

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

Conditions
ConditionsYield
With ammonium hydroxide In ethanol
bis-2,2-mercaptopropionylglycine

bis-2,2-mercaptopropionylglycine

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

Conditions
ConditionsYield
With sulfuric acid; zinc
α-Benzoylmercaptopropionylglycin
6183-01-3

α-Benzoylmercaptopropionylglycin

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

Conditions
ConditionsYield
With ammonium hydroxide for 1h; Ambient temperature;
α-Benzylmercaptopropionylglycin
6183-04-6

α-Benzylmercaptopropionylglycin

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

Conditions
ConditionsYield
With ammonia; sodium
C38H43N5O9S

C38H43N5O9S

A

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

B

biliverdin IXα
902268-70-6

biliverdin IXα

Conditions
ConditionsYield
In dimethyl sulfoxide at 27.5℃; Equilibrium constant; further solvent;
2-methylmercaptoacetyl chloride
144122-68-9

2-methylmercaptoacetyl chloride

glycine
56-40-6

glycine

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

Conditions
ConditionsYield
With sodium carbonate at 0℃; for 5h;190 g
conc. aqueous HCl

conc. aqueous HCl

diethyl ether
60-29-7

diethyl ether

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

N-(hydroxymethyl)benzamide
6282-02-6

N-(hydroxymethyl)benzamide

N-[2-(S-benzamidomethyl)mercaptopropionyl]glycine

N-[2-(S-benzamidomethyl)mercaptopropionyl]glycine

Conditions
ConditionsYield
In water94.4%
4-(3-Oxo-3H-benzo[d)-isothiazol-2-yl)benzenesulfonamide
4369-80-6

4-(3-Oxo-3H-benzo[d)-isothiazol-2-yl)benzenesulfonamide

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

{2-[2-(4-Sulfamoylphenylcarbamoyl)phenyldisulfanyl]propionylamino}-acetic acid

{2-[2-(4-Sulfamoylphenylcarbamoyl)phenyldisulfanyl]propionylamino}-acetic acid

Conditions
ConditionsYield
In tetrahydrofuran; methanol at 60℃; for 0.5h;93%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

N-methyl bromomaleimide
65060-93-7

N-methyl bromomaleimide

S-(N-methylmaleimide-3-yl)-tiopronin

S-(N-methylmaleimide-3-yl)-tiopronin

Conditions
ConditionsYield
Stage #1: N-(2-mercaptopropionyl)glycine; N-methyl bromomaleimide With triethylamine In tetrahydrofuran at 20℃; for 0.5h;
Stage #2: With sodium hydrogen sulfate; magnesium sulfate In tetrahydrofuran at 20℃; for 1h;
92%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

hematoporphyrin IX dihydrochloride
17696-69-4

hematoporphyrin IX dihydrochloride

7,12-bis<1-<1-(glycinocarbonyl)ethylthio>ethyl>-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoic acid

7,12-bis<1-<1-(glycinocarbonyl)ethylthio>ethyl>-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoic acid

Conditions
ConditionsYield
With L-valine; acetic acid for 0.666667h; Ambient temperature;90%
ethanol
64-17-5

ethanol

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

{2-[1-methyl-1-(4-methyl-cyclohex-3-enyl)-ethylsulfanyl]-propionylamino}-acetic acid ethyl ester

{2-[1-methyl-1-(4-methyl-cyclohex-3-enyl)-ethylsulfanyl]-propionylamino}-acetic acid ethyl ester

Conditions
ConditionsYield
With zinc(II) chloride In dichloromethane at 20℃; for 0.5h;87%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

7-methoxy-3-(1H-benzotriazol-1-ylcarbonyl)-2H-chromene-2-one
1286276-26-3

7-methoxy-3-(1H-benzotriazol-1-ylcarbonyl)-2H-chromene-2-one

2-{2-[(7-methoxy-2-oxo-2H-chromene-3-carbonyl)thio]propanamido}acetic acid
1286277-50-6

2-{2-[(7-methoxy-2-oxo-2H-chromene-3-carbonyl)thio]propanamido}acetic acid

Conditions
ConditionsYield
Stage #1: N-(2-mercaptopropionyl)glycine; 7-methoxy-3-(1H-benzotriazol-1-ylcarbonyl)-2H-chromene-2-one In methanol; water at 20℃; for 0.0833333h;
Stage #2: With potassium hydrogencarbonate In methanol; water at 20℃; for 0.0833333h;
85%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

3-(1H-benzotriazol-1-ylcarbonyl)-7-(diethylamino)-2H-chromen-2-one
1286276-78-5

3-(1H-benzotriazol-1-ylcarbonyl)-7-(diethylamino)-2H-chromen-2-one

2-(2-{[7-(diethylamino)-2-oxo-2H-chromene-3-carbonyl]thio}propanamido)acetic acid
1327278-89-6

2-(2-{[7-(diethylamino)-2-oxo-2H-chromene-3-carbonyl]thio}propanamido)acetic acid

Conditions
ConditionsYield
Stage #1: N-(2-mercaptopropionyl)glycine; 3-(1H-benzotriazol-1-ylcarbonyl)-7-(diethylamino)-2H-chromen-2-one In methanol; water at 20℃; for 0.0833333h;
Stage #2: With potassium hydrogencarbonate In methanol; water at 20℃; for 0.0833333h;
80%
dimethyl-4-nitrophenylsulfonium trifluoromethanesulfonate

dimethyl-4-nitrophenylsulfonium trifluoromethanesulfonate

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

(2-((4-nitrophenyl)thio)propanoyl)glycine

(2-((4-nitrophenyl)thio)propanoyl)glycine

Conditions
ConditionsYield
With caesium carbonate In N,N-dimethyl-formamide at 20℃; for 3h; Inert atmosphere; Schlenk technique;78%
ethanol
64-17-5

ethanol

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

D-limonene
5989-27-5

D-limonene

{2-[1-methyl-1-(4-methyl-cyclohex-3-enyl)-ethylsulfanyl]-propionylamino}-acetic acid ethyl ester

{2-[1-methyl-1-(4-methyl-cyclohex-3-enyl)-ethylsulfanyl]-propionylamino}-acetic acid ethyl ester

Conditions
ConditionsYield
With zinc(II) chloride In dichloromethane at 20℃; for 0.5h;76%
1,10-Phenanthroline
66-71-7

1,10-Phenanthroline

VOCl2*2CH3CN

VOCl2*2CH3CN

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

triethylamine
121-44-8

triethylamine

HN(C2H5)3(1+)*VO(C12H8N2)(SCH2CH2CONCH2CO2)(1-) = [HN(C2H5)3][VO(C12H8N2)(SCH2CH2CONCH2CO2)]

HN(C2H5)3(1+)*VO(C12H8N2)(SCH2CH2CONCH2CO2)(1-) = [HN(C2H5)3][VO(C12H8N2)(SCH2CH2CONCH2CO2)]

Conditions
ConditionsYield
In acetonitrile (argon); addn. of 1,10-phenanthroline to VOCl2*2MeCN in MeCN at -15°C, stirring (15 min), addn. of the dipeptide and NEt3 in MeCN, stirring (6 h); filtration, washing (Et2O), drying; elem. anal.;75%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

N-propionylglycine
21709-90-0

N-propionylglycine

Conditions
ConditionsYield
With triethyl borane; tributylphosphine; triethyl phosphite In acetonitrile for 36h; Irradiation;71%
methanol
67-56-1

methanol

[2,2]bipyridinyl
366-18-7

[2,2]bipyridinyl

sodium acetate dihydrate

sodium acetate dihydrate

vanadyl(IV) sulphate pentahydrate

vanadyl(IV) sulphate pentahydrate

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

[(V(IV)O)2(μ-OH)(μ-OAc)(μ-(N-2-mercapto-propionyl-glycine disulfide-H2)(2,2'-bipyridine)2]*1.68MeOH*0.75H2O

[(V(IV)O)2(μ-OH)(μ-OAc)(μ-(N-2-mercapto-propionyl-glycine disulfide-H2)(2,2'-bipyridine)2]*1.68MeOH*0.75H2O

Conditions
ConditionsYield
With O2 In methanol byproducts: Na2SO4, CH3COOH; by treating V-contg. compd. (0.8 mmol) in CH3OH with 2,2'-bipyridine (0.8 mmol), S-contg. compd. (0.8 mmol) and CH3CO2Na*2H2O (1.6 mmol); stirring for ca. 1 h; the soln. was filtered in order to remove Na2SO4; the filtrate was allowed to stand for 3-4 d; elem. anal.;71%
hexaamminenickel (II) chloride

hexaamminenickel (II) chloride

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

3NH4(1+)*Ni3(C5H6NO3S)3(3-)*3CH3OH*0.5(C2H5)2O=(NH4)3{Ni3(C5H6NO3S)3}*3CH3OH*0.5(C2H5)2O

3NH4(1+)*Ni3(C5H6NO3S)3(3-)*3CH3OH*0.5(C2H5)2O=(NH4)3{Ni3(C5H6NO3S)3}*3CH3OH*0.5(C2H5)2O

Conditions
ConditionsYield
In water; N,N-dimethyl-formamide byproducts: NH4Cl; Addn. of MPG-soln. in DMF to a soln. of Ni-complex im DMF/H2O with stirring (N2), stirring (1 h, 50°C).; Concg., filtn. of NH4Cl, addn. of CH3Cn to the filtrate, storing (12 h, -20°C), filtn., recrystn. (CH3OH/diethyl ether), elem. anal.;70%
methanol
67-56-1

methanol

1,10-Phenanthroline
66-71-7

1,10-Phenanthroline

sodium acetate dihydrate

sodium acetate dihydrate

vanadyl(IV) sulphate pentahydrate

vanadyl(IV) sulphate pentahydrate

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

[(V(IV)O)2(μ-OH)(μ-OAc)(μ-(N-2-mercapto-propionyl-glycine disulfide-H2)(1,10-phenanthroline)2]*1.40MeOH*0.81H2O

[(V(IV)O)2(μ-OH)(μ-OAc)(μ-(N-2-mercapto-propionyl-glycine disulfide-H2)(1,10-phenanthroline)2]*1.40MeOH*0.81H2O

Conditions
ConditionsYield
With O2 In methanol byproducts: Na2SO4, CH3COOH; by treating V-contg. compd. (0.8 mmol) in CH3OH with 1,10-phenanthroline(0.8 mmol), S-contg. compd. (0.8 mmol) and CH3CO2Na*2H2O (1.6 mmol); st irring for ca. 1 h; the soln. was filtered in order to remove Na2SO4; the filtrate was allowed to stand for 3-4 d; elem. anal.;66%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

8-bromocaffeine
10381-82-5

8-bromocaffeine

C13H17N5O5S

C13H17N5O5S

Conditions
ConditionsYield
With diisopropylammonium bis(catecholato)isobutylsilicate; Ni[(4,4′-di-tert-butyl-2,2′-bipyridine)(H2O)4]Cl2; [Ru(bpy)3](PF6)2 In N,N-dimethyl-formamide at 20℃; Irradiation;66%
[(n-C4H9)4N][ReOCl3(o-OC6H4P(C6H5)2)]

[(n-C4H9)4N][ReOCl3(o-OC6H4P(C6H5)2)]

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

ReO(tioproninato)(o-diphenylphosphinophenolato)[(n-C4H9)4N]

ReO(tioproninato)(o-diphenylphosphinophenolato)[(n-C4H9)4N]

Conditions
ConditionsYield
In methanol; acetonitrile ligand/MeOH added to Re complex/MeCN, refluxed for 60 min; solvent removed (vac.), residue dissolved in CH2Cl2, chromd. (SiO2, CH2Cl2/MeOH), concd., MeOH added, crystd. by slow evapn. at room remp.; elem. anal.;65%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

3-(1H-benzotriazol-1-ylcarbonyl)-2H-chromene-2-one
312929-01-4

3-(1H-benzotriazol-1-ylcarbonyl)-2H-chromene-2-one

2-{2-[(2-oxo-2H-chromene-3-carbonyl)thio]propanamido}acetic acid
1286329-96-1

2-{2-[(2-oxo-2H-chromene-3-carbonyl)thio]propanamido}acetic acid

Conditions
ConditionsYield
Stage #1: N-(2-mercaptopropionyl)glycine; 3-(1H-benzotriazol-1-ylcarbonyl)-2H-chromene-2-one In methanol; water at 20℃; for 0.0833333h;
Stage #2: With potassium hydrogencarbonate In methanol; water at 20℃; for 0.0833333h;
65%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

para-bromoacetophenone
99-90-1

para-bromoacetophenone

C13H15NO4S

C13H15NO4S

Conditions
ConditionsYield
With diisopropylammonium bis(catecholato)isobutylsilicate; Ni[(4,4′-di-tert-butyl-2,2′-bipyridine)(H2O)4]Cl2; [Ru(bpy)3](PF6)2 In N,N-dimethyl-formamide at 20℃; Irradiation;64%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

4-bromobenzenecarbonitrile
623-00-7

4-bromobenzenecarbonitrile

C12H12N2O3S

C12H12N2O3S

Conditions
ConditionsYield
With diisopropylammonium bis(catecholato)isobutylsilicate; Ni[(4,4′-di-tert-butyl-2,2′-bipyridine)(H2O)4]Cl2; [Ru(bpy)3](PF6)2 In N,N-dimethyl-formamide at 20℃; Irradiation;61%
3-bromo-5-chloropyridine
73583-39-8

3-bromo-5-chloropyridine

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

C10H11ClN2O3S

C10H11ClN2O3S

Conditions
ConditionsYield
With diisopropylammonium bis(catecholato)isobutylsilicate; Ni[(4,4′-di-tert-butyl-2,2′-bipyridine)(H2O)4]Cl2; [Ru(bpy)3](PF6)2 In N,N-dimethyl-formamide at 20℃; Irradiation;56%
5-bromopyrimidine
4595-59-9

5-bromopyrimidine

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

C9H11N3O3S

C9H11N3O3S

Conditions
ConditionsYield
With diisopropylammonium bis(catecholato)isobutylsilicate; Ni[(4,4′-di-tert-butyl-2,2′-bipyridine)(H2O)4]Cl2; [Ru(bpy)3](PF6)2 In N,N-dimethyl-formamide at 20℃; Irradiation;56%
ethyl Bromopyruvate
70-23-5

ethyl Bromopyruvate

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

3-[1-(carboxymethyl-carbamoyl)-ethylsulfanyl]-2-hydroxy-acrylic acid ethyl ester

3-[1-(carboxymethyl-carbamoyl)-ethylsulfanyl]-2-hydroxy-acrylic acid ethyl ester

Conditions
ConditionsYield
In ethanol; water; acetonitrile53.3%
In ethanol; water; acetonitrile53.3%
2-chloro-1-(thiazolidin-3-yl)-1-oxoethane
52837-50-0

2-chloro-1-(thiazolidin-3-yl)-1-oxoethane

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

2-[2-[(3-thiazolidyl)carbonylmethylthio]-propionamide]acetic acid

2-[2-[(3-thiazolidyl)carbonylmethylthio]-propionamide]acetic acid

Conditions
ConditionsYield
52%
52%
diethyl ether
60-29-7

diethyl ether

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

N-(hydroxymethyl)acetamide
625-51-4

N-(hydroxymethyl)acetamide

N-[2-(S-acetamidomethyl)mercaptopropionyl]glycine

N-[2-(S-acetamidomethyl)mercaptopropionyl]glycine

Conditions
ConditionsYield
With hydrogenchloride In water50.2%
4-[4-(1,1'-biphenyl-4-ylcarbonyl)piperazin-1-yl]-2-chloro-6-ethylthieno[2,3-d]pyrimidine
902765-53-1

4-[4-(1,1'-biphenyl-4-ylcarbonyl)piperazin-1-yl]-2-chloro-6-ethylthieno[2,3-d]pyrimidine

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

N-[2-({4-[4-(1,1'-biphenyl-4-ylcarbonyl)piperazin-1-yl]-6-ethylthieno[2,3-d]pyrimidin-2-yl}thio)propanoyl]glycine

N-[2-({4-[4-(1,1'-biphenyl-4-ylcarbonyl)piperazin-1-yl]-6-ethylthieno[2,3-d]pyrimidin-2-yl}thio)propanoyl]glycine

Conditions
ConditionsYield
With 1,8-diazabicyclo[5.4.0]undec-7-ene In N,N-dimethyl-formamide for 24h;43%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

2-bromo-5-(trifluoromethyl)pyridine
50488-42-1

2-bromo-5-(trifluoromethyl)pyridine

C11H11F3N2O3S

C11H11F3N2O3S

Conditions
ConditionsYield
With diisopropylammonium bis(catecholato)isobutylsilicate; Ni[(4,4′-di-tert-butyl-2,2′-bipyridine)(H2O)4]Cl2; [Ru(bpy)3](PF6)2 In N,N-dimethyl-formamide at 20℃; Irradiation;43%
1-hydroxy-pyrrolidine-2,5-dione
6066-82-6

1-hydroxy-pyrrolidine-2,5-dione

N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

(2-mercapto-propionylamino)acetic acid 2,5-dioxopyrrolidin-1-ylester
753457-40-8

(2-mercapto-propionylamino)acetic acid 2,5-dioxopyrrolidin-1-ylester

Conditions
ConditionsYield
With dicyclohexyl-carbodiimide In tetrahydrofuran at 20℃; for 24h;32%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

5-bromo-2'-deoxyuridine
59-14-3

5-bromo-2'-deoxyuridine

C14H19N3O8S

C14H19N3O8S

Conditions
ConditionsYield
With diisopropylammonium bis(catecholato)isobutylsilicate; Ni[(4,4′-di-tert-butyl-2,2′-bipyridine)(H2O)4]Cl2; [Ru(bpy)3](PF6)2 In N,N-dimethyl-formamide at 20℃; Irradiation;31%
N-(2-mercaptopropionyl)glycine
1953-02-2

N-(2-mercaptopropionyl)glycine

6-Methyl-thiomorpholine-2,5-dione
80142-35-4

6-Methyl-thiomorpholine-2,5-dione

Conditions
ConditionsYield
With chloroformic acid ethyl ester; triethylamine In dichloromethane for 16h; Ambient temperature;30%

1953-02-2Relevant articles and documents

Light-Induced Formation/Scission of C-N, C-O, and C-S Bonds Enables Switchable Stability/Degradability in Covalent Systems

Hai, Yu,Li, Ziyi,Lu, Hanwei,Ye, Hebo,You, Lei,Zou, Hanxun

supporting information, p. 20368 - 20376 (2021/12/03)

The manipulation of covalent bonds could be directed toward degradable, recyclable, and sustainable materials. However, there is an intrinsic conflict between properties of stability and degradability. Here we report light-controlled formation/scission of three types of covalent bonds (C-N, C-O, and C-S) through photoswitching between equilibrium and nonequilibrium states of dynamic covalent systems, achieving dual benefits of photoaddressable stability and cleavability. The photocyclization of dithienylethene fused aldehyde ring-chain tautomers turns on the reactivity, incorporating/releasing amines, alcohols, and thiols reversibly with high efficiency, respectively. Upon photocycloreversion the system is shifted to kinetically locked out-of-equilibrium form, enabling remarkable robustness of covalent assemblies. Reaction coupling allows remote and directional control of a diverse range of equilibria and further broadens the scope. Through locking and unlocking covalent linkages with light when needed, the utility is demonstrated with capture/release of bioactive molecules, modification of surfaces, and creation of polymers exhibiting tailored stability and degradability/recyclability. The versatile toolbox for photoswitchable dynamic covalent reactions to toggle matters on and off should be appealing to many endeavors.

Preparation methods of tiopronin and zinc complex of tiopronin

-

Paragraph 0038; 0039, (2017/02/24)

The invention discloses preparation methods of tiopronin and zinc complex of tiopronin and belongs to the technical field of a medicine compound for relieving acute/chronic liver diseases. The technical scheme is characterized in that the formula is shown in the specification. The operation is simple, the cost of raw materials is low, the repeatability of experimental results of a process route is higher, and the production cost can be remarkably reduced.

Carotenoid analogs or derivatives for controlling C-reactive protein levels

-

, (2008/06/13)

A method of controlling (e.g., influencing or affecting) C-reactive protein levels in a subject may include administering to the subject an effective amount of a pharmaceutically acceptable formulation. The pharmaceutically acceptable formulation may include a synthetic analog or derivative of a carotenoid. The subject may be administered a carotenoid analog or derivative, either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation. The carotenoid analog may include a conjugated polyene with between 7 to 14 double bonds. The conjugated polyene may include an acyclic alkene including at least one substituent and/or a cyclic ring including at least one substituent. In some embodiments, a carotenoid analog or derivative may include at least one substituent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1953-02-2